Joseph Erlinger files Form 144 reporting 10b5-1 sales

Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting proposed sales of Common Stock tied to 10b5-1 arrangements for Joseph Erlinger.

Accepted by SEC EDGAR 03/23/2026 - 04:36 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting proposed sales of Common Stock tied to 10b5-1 arrangements for Joseph Erlinger. The filing lists multiple recent 10b5-1 sales: 2,626 shares on 03/10/2026 ($862,220.84), 333 shares on 02/23/2026 ($110,033.19), and earlier 10b5-1 sales on 02/10/2026 and 01/12/2026 with shares listed as 2,626 on each date and corresponding dollar amounts. The filing identifies Performance Restricted Stock Units dated 02/13/2026 and shows the broker/dealer as Morgan Stanley Smith Barney LLC in New York.

Insights

Insider Transactions Analyst

Form 144 records routine, pre-arranged 10b5-1 sales by Joseph Erlinger.

The notice lists specific 10b5-1 dispositions: 2,626 shares (03/10/2026), 333 shares (02/23/2026), and matching 2,626 entries on 02/10/2026 and 01/12/2026 with dollar amounts shown. These are reported sales rather than new grants.

Cash‑flow treatment and whether other shares remain subject to restriction are not detailed in the excerpt; subsequent filings will show final settlement and any remaining holdings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for MCD show about Joseph Erlinger?

It reports proposed sales of Common Stock under 10b5-1 plans by Joseph Erlinger. The filing lists specific sale dates and amounts, including 2,626 shares on 03/10/2026 and 333 shares on 02/23/2026 with dollar figures shown.

Which broker handled the reported transactions in the Form 144?

The broker/dealer named is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY. The notice attributes the proposed sales to that firm in the filing excerpt.

Were the sales described in the Form 144 executed under a trading plan?

Yes, the filing identifies the transactions as 10b5-1 sales for Joseph Erlinger, indicating they were effected under a pre-arranged trading plan rather than as unscheduled open-market trades.

Does the Form 144 disclose proceeds from the listed sales?

The excerpt provides dollar amounts alongside each sale date, for example $862,220.84 for the 2,626-share sale on 03/10/2026 and $110,033.19 for the 333-share sale on 02/23/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001685800
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	McDONALDs CORPORATION
SEC File Number	001-05231
Address of Issuer	110 North Carpenter Street Chicago ILLINOIS 60607
Phone	6306233000
Name of Person for Whose Account the Securities are To Be Sold	JOSEPH ERLINGER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	333	102847.05	710398642	03/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Performance Restricted Stock Units	Issuer			333	02/13/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	03/10/2026	2626	862220.84
10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	02/23/2026	333	110033.19
10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	02/10/2026	2626	854106.50
10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	01/12/2026	2626	805068.58

144: Remarks and Signature

Remarks
Date of Notice	03/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joe Erlinger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)